|
|
|
|
LEADER |
00000cam a2200000Mi 4500 |
001 |
ocn923261160 |
003 |
OCoLC |
005 |
20241006213017.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
151010s1900 dcu o 000 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d MERUC
|d OCLCQ
|d ZCU
|d ICG
|d OCLCO
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCQ
|d DKC
|d AU@
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|d OCLCQ
|
020 |
|
|
|a 9780309589505
|
020 |
|
|
|a 0309589509
|
035 |
|
|
|a (OCoLC)923261160
|
043 |
|
|
|a n-us---
|
050 |
|
4 |
|a RM170.B565
|
049 |
|
|
|a HCDD
|
100 |
1 |
|
|a Institute of Medicine, Forum on Blood Safety.
|
245 |
1 |
0 |
|a Blood Banking and Regulation :
|b Procedures, Problems, and Alternatives.
|
260 |
|
|
|a Washington :
|b National Academies Press,
|c 1900.
|
300 |
|
|
|a 1 online resource (140 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a ""Blood Banking and Regulation: Procedures, Problems, and Alternatives""; ""Copyright""; ""Foreword""; ""Preface""; ""Contents""; ""I Overview of Regulatory and Policy-Making Procedures in Blood Banking""; ""FDA Policy and Regulation""; ""THE REGULATORY MANDATE""; ""REGULATORY MECHANISMS""; ""LEGAL AUTHORITIES""; ""REGULATION AND ENFORCEMENT AT FDA""; ""ENSURING BLOOD SAFETY AND AVAILABILITY IN THE FUTURE""; ""CDC Recommendations""; ""CDC'S MISSION""; ""EFFECTIVENESS OF CDC""; ""RESEARCH ON HIV""; ""HOW CDC AFFECTS POLICY""; ""FORMAL RECOMMENDATIONS""
|
505 |
8 |
|
|a ""Blood Banking's Policy Groups and Procedures""""THE TRADITION OF SELF-REGULATION""; ""STANDARD-SETTING ORGANIZATIONS""; ""AMERICAN ASSOCIATION OF BLOOD BANKS""; ""JOINT EFFORTS""; ""OTHER STANDARDS AND GUIDELINES""; ""Opportunities and Venues for Dialogue""; ""THE CHANGING CLIMATE IN BLOOD BANKING""; ""VENUES FOR DIALOGUE""; ""THE BLOOD PRODUCTS ADVISORY COMMITTEE""; ""OTHER VENUES FOR DIALOGUE""; ""THE VOICE OF BLOOD PRODUCT CONSUMERS""; ""ATTENDING TO THE DONOR""; ""REGULATORY DIFFICULTIES""; ""Discussion""; ""II Regulatory Enforcement And Compliance""; ""CBER Compliance Activity""
|
505 |
8 |
|
|a ""COORDINATION BETWEEN THE CENTERS AND THE FIELD""""OFFICE OF REGULATORY AFFAIRS""; ""INSPECTION CONSISTENCY""; ""INSPECTIONS AND ENFORCEMENT""; ""FDA Practice in the Field""; ""TRAINING FOR THE FIELD""; ""SOURCES OF CONSISTENCY""; ""Challenges and Questions About Compliance""; ""IMPROVEMENTS IN SAFETY""; ""QUESTIONS ABOUT ENFORCEMENT""; ""Evidence That Compliance Works""; ""Indirect Effects: ""Bulletproofing""""; ""Is Compliance Improving?""; ""REGULATION AND OTHER FORCES""; ""Discussion""; ""III Innovations and Alternatives in Regulation""; ""Regulatory Alternatives""
|
505 |
8 |
|
|a ""REGULATORY DIAGNOSIS AND MISMATCH""""MAXIMIZING EFFECTIVENESS AND EFFICIENCY""; ""PROPOSED ALTERNATIVES TO COMMAND-AND-CONTROL""; ""Specific Techniques""; ""ACUS STUDY AND RECOMMENDATIONS""; ""THE ADMINISTRATIVE PROCEDURE ACT""; ""THE ALTERNATIVE: NEGOTIATION""; ""RECENT DEVELOPMENTS AND THE FEDERAL ADVISORY COMMITTEE ACT (FACA)""; ""AUDITED SELF-REGULATION""; ""Negotiated Rule-Making""; """"REG-NEG""�DOES IT WORK?""; ""THE PUBLIC AT THE NEGOTIATION TABLE""; ""CONSENSUS""; ""DECISION-MAKING DYNAMICS""; ""BENEFITS OF COLLABORATION""; ""POLITICAL CONSENSUS""; ""REG-NEG OUTCOMES""
|
505 |
8 |
|
|a ""GETTING REG-NEG STARTED""""CHOOSING THE PROBLEM""; ""OTHER REQUISITES""; ""CONSTITUENCY PRESSURES""; ""ACCOUNTABILITY""; ""REG-NEG PROCESS""; ""QUESTIONS ABOUT REG-NEG""; ""Panel Discussion on Applications of Negotiated Rule-Making to Issues in Blood Banking""; ""Kathryn C. Zoon""; ""REGULATORY INITIATIVES AT FDA""; ""FDA IN THE FUTURE""; ""INITIATIVES AT CBER""; ""WILLINGNESS TO EXPLORE PILOTS""; ""Jay Epstein""; ""INITIATIVES IN BLOOD REGULATION""; ""PARTICIPATORY DECISION-MAKING""; ""PUBLIC MEETINGS""; ""NATIONAL PERFORMANCE REVIEW""; ""EXPERIMENTS IN REGULATION""
|
500 |
|
|
|a ""The forces of change""
|
650 |
|
0 |
|a Blood banks
|x Safety regulations
|z United States.
|
650 |
|
0 |
|a Blood
|x Transfusion
|x Safety regulations
|z United States.
|
650 |
|
7 |
|a Blood banks
|x Safety regulations
|2 fast
|
651 |
|
7 |
|a United States
|2 fast
|1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq
|
700 |
1 |
|
|a Dauer, Edward A.
|
776 |
0 |
8 |
|i Print version:
|a Institute of Medicine, Forum on Blood Safety.
|t Blood Banking and Regulation : Procedures, Problems, and Alternatives.
|d Washington : National Academies Press, ©1900
|z 9780309055468
|
856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=3376101
|y Click for online access
|
903 |
|
|
|a EBC-AC
|
994 |
|
|
|a 92
|b HCD
|